SRSokhib Zamon Ogli Rashidov

Sokhib Zamon Ogli Rashidov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sokhib Zamon Ogli Rashidov has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Preclinical Evaluation of Antiarrhythmic Drugs Against Atrial Fibrillation in Experimental Animal Models

    by Mayram Miralievna Boltaeva, Zafar Isomiddinovich Sanoev, Tolmas Tolibovich Khamroev, Ravshan Komiljonovich Sultonov, Sirojiddin Rashidovich Kenjaev, Nilufar Makhsudovna Dushaeva, Bakhtiyor Bakhodiro’G’LI Abdurasulov, Odinakhon Ubaydullaevna Ikramova, Qobiljon G’OFirjono’G’LI Sobirov, Abduqodir Abdurashidovich Qobulov, et al.

    CVD are the leading cause of death and disability worldwide and arrhythmias, in particular AF, are one of the main causes of death and disability from CVD. In this regard, the main purpose of the work is to conduct preclinical studies on the analysis of promising anti-ventricular fibrillation, as well as anti-atrial fibrillation among known drugs with antiarrhythmic activity, widely used in medical practice. The studies used white mice with a body weight of 18-22 g and white woolless rats with a body weight of 180-250 g. The experiments studied the antiarrhythmic activity of drugs with antiarrhythmic activity of allapinine in doses from 0.05 to 1.5 mg/kg, propafenone from 3 to 10 mg/kg and Amiodarone in doses from 45 to 60 mg/kg administered orally to experimental animals. Rhythm disturbances of peripheral origin were caused by the administration of 15 mg/kg of aconitine and barium chloride, 250 mg/kg of calcium chloride, 0.22 mcg/kg of adrenal hydrochloride and AF by injecting 200 mcg/kg of aconitine into the tail vein of experimental animals. In the conducted studies, allapinine, propafenone and amiodarone also primarily eliminated ventricular rhythm disturbances and then restored the rhythm of the atria. Although the instructions for the use of these drugs in clinical practice also mention ventricular rhythm disorders, in practice we see that these drugs mainly eliminate ventricular rhythm disorders. The quest for methods to broaden the scope of the use of medications that prevent AF is still relevant in medical practice, even though large-scale, important studies of antiarrhythmic pharmaceuticals are now being conducted worldwide.

  • Open Access

    Synthesis and Antidepressant Activity of 5-(2-Aminophenyl)-1,3,4-Oxadiazole-2-(3H)-Thione

    by Zafar Isomiddinovich Sanoev, Sokhib Zamon Ogli Rashidov, Tolmas Tolibovich Khamroev, Ibrokhimjon Tuychievich Abdinazarov, Sukhrob Davlatyor Ogli Rakhimboev, Dilnoza Safaralievna Ismailova, Burkhon Zhuraevich Elmuradov, Madina Aladdin Kizi Shakhmurova

    Many psychiatrists have consistently pointed out the link between stressors and the emergence of depressed moods. Both acute traumatic experiences and long-term psychogenic stress can contribute to the development of depressive disorders in people. The aim of this research is to develop a novel antidepressant medication based on compound-1, 5-(2-aminophenyl)-1,3,4-oxadiazole-2-(3H)-thione. The reference medication fluoxetine and 5-(2-aminophenyl)-1,3,4-oksadiazole-2(3H)-thione (compound 1) were the subjects of the investigation. Their effects were evaluated using models such as the FST and TST, which measure behavioral despair and immobility in response to stress. Other factors that were assessed included acute toxicity, locomotor activity, research activities, anti-anxiety activity, and the spectrum of antidepressant action. In all studies, chemical 1 was administered orally at dosages of 0.1, 0.5, 1.0, 5.0, 10.0, 30.0, and 60.0 mg/kg. Experiments conducted on models of stress-induced depression revealed that compound-1 has a strong antidepressant effect when given once to mice (male and female). Under compound-1's influence, the animals' total immobilization time decreased and the latency period before the onset of immobility increased statistically substantially in the "non-escapable forced Porsolt swimming" and "hanging mice by the tail" tests. Under the effect of the test drug, the number of jumps made by the animals and the total amount of time spent actively swimming increased statistically considerably in the "non-escapable forced swimming, but Porsolt" test. The uniqueness and benefits of compound-1 as a possible antidepressant medication have therefore been demonstrated by neuro- and psychopharmacological research comparing it to the well-known antidepressant fluoxetine.


  • Open Access

    Synthesis and Research Anticonvulsant Activity of Annulated Triazolo-Thiadiazine Derivative in Laboratory Animals

    by Zafar Isomiddinovich Sanoev, Dilnoza Safaralievna Ismailova, Sukhrob Davlatyor Ogli Rakhimboev, Tolmas Tolibovich Khamroev, Burkhon Zhuraevich Elmuradov, Ibrokhimjon Tuychievich Abdinazar, Sokhib Zamon Ogli Rashidov

    Epilepsy is a chronic non-communicable disease of the brain, which is estimated that five million people are diagnosed with epilepsy every year worldwide. In this regard the study studied the anticonvulsant properties of annulated 4-(6-phenyl-7H-[1,2,4] triazolo [3,4-b] [1,3,4] thiadiazin-3-yl)-aniline. Anticonvulsant activity was evaluated in various experimental models of convulsions in laboratory rodents. Oral dosages of 3, 10, 30, and 60 mg/kg of the study substances were given one hour prior to the experiment. Pentylenetetrazole (PTZ) convulsions were modeled using PTZ at a dose of 7 mg/kg subcutaneously, isoniazid convulsions were modeled using an oral dose of 300 mg/kg, and bicuculline convulsions were modeled using a subcutaneous dose of 2,7 mg/kg. Also, comparatively studied the antiepileptic activity of triazole derivatives with the well-known antiepileptic drug carbamazepine. In the conducted studies the studied compound showed carbamazepine-like activity at doses of 3 and 10 mg/kg in the model of seizures caused by strychnine, while at a dose of 30 mg/kg it showed high activity and in models induced using bicuculin and isoniazid, the studied drug showed activity similar to carbamazepine. On the contrary, the model of seizures induced by PTZ showed high activity at doses of 3, 10 and 30 mg/kg. The results obtained showed that triazole derivative had a pronounced antiepileptic activity, and further study can be proposed as a potential antiepileptic drug.